Search Results
Oct 22, 2025, 16:05 ET SAP Quarterly Statement Q3 2025
the engagement will result in material impact on its financial performance. In September, SAP National Security Services (SAP NS2®) was awarded a $1 billion firm-fixed-price Indefinite Delivery/Indefinite Quantity (IDIQ) contract from the United States Army for an end-user license
More news about: SAP SE
Oct 22, 2025, 08:40 ET Discover Halifax Partners with GuideGeek to Launch AI Travel Genius for Visitors
HALIFAX, NS, Oct. 22, 2025 /PRNewswire/ -- Travelers planning a trip to Halifax Regional Municipality (HRM) can now rely on Halifax AI, an AI travel genius that provides instant answers to
More news about: Matador Network
Oct 22, 2025, 08:07 ET CND Life Sciences Announces NIH Grant to Study the Risk of Parkinson's Disease in Patients with Essential Tremor
Institute of Neurological Disorders and Stroke and the National Institute on Aging (NIA) of the National Institutes of Health under Award Number R44NS143486. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
More news about: CND Life Sciences
Oct 21, 2025, 09:35 ET SOLID-STATE MAGNETRON TRANSMITTERS SHAPE THE WAVEFORM USING MARX TOPOLOGY
transmitter technologies including cathode, mod-anode, and grid pulsed. Providing precise RF control to within < 0.1% and 50 ns rise/fall, adjustable from pulse-to-pulse, and support pulse repetition frequencies up to 400 kHz, DTI PowerMod™ High Power Solid-State Magnetron Transmitters
More news about: Diversified Technologies, Inc.
Oct 17, 2025, 04:38 ET Duchenne Muscular Dystrophy Therapeutics Market Surges Toward $6.6B by 2033 as Gene and RNA Therapies Redefine Treatment Paradigm | by DataM Intelligence
commitment to orphan drug reimbursement and cutting-edge biotech collaborations. Domestic leaders such as Nippon Shinyaku (NS Pharma) continue to strengthen their market footprint with Viltepso, while Japan's favorable reimbursement system encourages adoption of high-cost
More news about: DataM Intelligence 4 Market Research LLP
Oct 16, 2025, 16:50 ET Precision BioLogic adquiere George King Bio-Medical
HALIFAX, NS, 16 de octubre de 2025 /PRNewswire/ --
More news about: Precision BioLogic
Oct 16, 2025, 16:48 ET Precision BioLogic acquiert George King Bio-Medical
HALIFAX, NS, 16 octobre 2025 /PRNewswire/ --
More news about: Precision BioLogic
Oct 16, 2025, 16:46 ET Precision BioLogic erwirbt George King Bio-Medical
HALIFAX, NS, 16. Oktober 2025 /PRNewswire/ --
More news about: Precision BioLogic
Oct 16, 2025, 08:30 ET Precision BioLogic Acquires George King Bio-Medical
HALIFAX, NS, Oct. 16, 2025 /PRNewswire/ -
More news about: Precision BioLogic
Oct 16, 2025, 08:30 ET Precision BioLogic Acquires George King Bio-Medical
HALIFAX, NS, Oct. 16, 2025 /PRNewswire/ --
More news about: Precision BioLogic
Oct 14, 2025, 09:15 ET ABK Biomedical Raises US$35M in Series D Financing
commercialization preparation HALIFAX, NS, Oct. 14, 2025 /PRNewswire/ - ABK Biomedical, Inc., an innovative medical device company dedicated to the research,
More news about: ABK Biomedical Inc.
Oct 14, 2025, 07:13 ET Brogidirsen (NS-089/NCNP-02) 3.5 Year Clinical Trial Data for the Treatment of Duchenne Muscular Dystrophy Presented at 2025 World Muscle Society Congress
wespeakduchenne.com. About NS Pharma, Inc.NS Pharma, Inc., is a wholly owned subsidiary of Nippon Shinyaku Co., Ltd. NS Pharma is a registered trademark of the Nippon Shinyaku Co., Ltd. For more information, please visit
More news about: NS Pharma, Inc.
Oct 10, 2025, 09:28 ET CodeMettle Awarded Unified Network Operations (UNO) Other Transaction (OT) Phase II Sub-Contract to Advance the U.S. Army's Unified Network
successful, competitive Phase I demonstration earlier this year at the Program Executive Office Command, Control, Communications, and Network's (PEO C3N's) lab at Aberdeen Proving Ground, Maryland. This award marks a critical step in advancing the Army's unified network strategy.
More news about: CodeMettle
Oct 09, 2025, 07:21 ET EXCEL Group Opens New Creola, AL Office Serving Eastern Gulf Coast and Eastern U.S. Regions
major industrial facilities, including Novelis Aluminum Facility, SSAB, Olin, PowerSouth, Chevron's Pascagoula Refinery, U.S. Steel's Fairfield Works, AM/NS Calvert, Alabama Power, and key shipyards along the Gulf Coast, enables EXCEL to provide timely and efficient services to its clients.
More news about: Excel Group
Oct 02, 2025, 12:13 ET SmartSkin Technologies wird vom kanadischen Netzwerk für Lebensmittelinnovation zu einem der Top-Foodtech-Führer Kanadas ernannt
Foodtech Frontier 25 Atlantic Showcase, das von CFIN am 15. Oktober 2025 veranstaltet wird, im Volta Incubator in Halifax, NS offiziell entgegennehmen. Null-Fehler-Produktion: Bewährte Ergebnisse für Lebensmittel-, Getränke- und
More news about: SmartSkin Technologies
Oct 02, 2025, 08:47 ET Rock Tech and ArcelorMittal Agree on Cooperation to Strengthen Regional Industrial Competence
countries. It is the largest steel producer in Europe, among the largest in the Americas, and has a growing presence in Asia through its joint venture AM/NS India. ArcelorMittal sells its products to a diverse range of customers including the automotive, engineering, construction and machinery industries,
More news about: Rock Tech Lithium Inc.
Oct 01, 2025, 07:30 ET SmartSkin Technologies Named One of Canada's Top Foodtech Leaders by the Canadian Food Innovation Network
during the Foodtech Frontier 25 Atlantic Showcase, hosted by CFIN on October 15, 2025, at the Volta Incubator in Halifax, NS. Zero-Defect Manufacturing: Proven Outcomes for Food, Beverage, and Pharmaceutical Producers
More news about: SmartSkin Technologies
Oct 01, 2025, 07:30 ET SmartSkin Technologies Named One of Canada's Top Foodtech Leaders by the Canadian Food Innovation Network
during the Foodtech Frontier 25 Atlantic Showcase, hosted by CFIN on October 15, 2025, at the Volta Incubator in Halifax, NS. Zero-Defect Manufacturing: Proven Outcomes for Food, Beverage, and Pharmaceutical Producers
More news about: SmartSkin Technologies
Sep 30, 2025, 11:15 ET Aisha Bowe Citizen Astronaut and Former NASA Aerospace Engineer and CEO of LINGO Presents Space Farming Study That Could Inform How We Eat in Space
astronaut and entrepreneur Aisha Bowe flew aboard Blue Origin's New Shepard (NS) 31 mission, she carried the question of how humans might one day grow food off-planet, and through this query, created a rare opportunity to design
More news about: LINGO
Sep 25, 2025, 11:15 ET InventHelp Inventors Develop New Lid for a Takeout Coffee Cup (TRO-1397)
keep a coffee cup lid clean and sanitary until ready for drinking by a consumer," said one of two inventors, from Bedford, NS, Canada, "so we invented the SAFE LID. Our design helps prevent the transfer of germs from a coffee server to the
More news about: InventHelp
Sep 24, 2025, 09:31 ET ResVita Bio Announces Positive FDA Pre-IND Meeting, Advancing RVB-003 Toward IND Filing for Netherton Syndrome in Early 2026
Netherton Syndrome (NS) is caused by mutations in the SPINK5 gene, leading to uncontrolled protease activity, chronic skin inflammation, and life-threatening barrier defects.
More news about: ResVita Bio
Sep 24, 2025, 07:00 ET HyVera Launches in the United States with Breakthrough Hydrogen-on-Demand Technology
HALIFAX, NS, Sept. 24, 2025 /PRNewswire/ - HyVera Distributed Energy today announced its official launch in the United States, bringing its hydrogen-on-demand (H2oD) technology to the American market.
More news about: HyVera Distributed Energy
Sep 22, 2025, 11:16 ET RNA-based Therapies Market to Reach USD 213.54 Billion by 2033, Driven by Rare Diseases, Oncology, and Advances in RNA Technologies | DataM Intelligence
therapies.PMDA's regulatory flexibility, supporting clinical trials for RNA-based therapies targeting rare and genetic diseases.In 2025, NS Pharma advanced multiple ASO-based therapies into late-stage trials, reinforcing Japan's leadership in neuromuscular
More news about: DataM Intelligence 4 Market Research LLP
Sep 19, 2025, 07:13 ET FDA Grants Orphan Drug Designation to NS-051/NCNP-04 for the Treatment of Duchenne Muscular Dystrophy
cause Duchenne, and NS-051/NCNP-04 is being developed to treat patients with confirmed gene mutations amenable to exon 51 skipping therapy. NS-051/NCNP-04 is an antisense oligonucleotide co-discovered by the National Center of Neurology and Psychiatry (NCNP) and Nippon Shinyaku. NS-051/NCNP-04 promotes
More news about: NS Pharma, Inc.
Sep 18, 2025, 08:45 ET Nektar Presents New Data from REZOLVE-AD Phase 2b Study for Rezpegaldesleukin in Late-Breaker Oral Presentation at EADV 2025
18% ns 17% ns
More news about: Nektar Therapeutics